Glidewell launches mini-implant system
Glidewell Laboratories has introduced the Inclusive Mini Implant System, small-diameter, self-tapping titanium implants that have been cleared by the U.S. Food and Drug Administration for
Glidewell Laboratories has introduced the Inclusive Mini Implant System, small-diameter, self-tapping titanium implants that have been cleared by the U.S. Food and Drug Administration for
Branam Oral Health Technologies has signed a national distribution contract with drugstore.com, giving Branam direct access to more than 3 million online customers for its
Komet USA has released the Komet SF8850 sonic tip for veneer-preparation finishing procedures. The tips are designed exclusively for use with the Komet SonicLine sonic
A former PhD student at the University of Bristol has been awarded first prize and the Paul Roell Medal in the prestigious Zwick Science Awards
Periodontal ligament stem cells (PDLSCs) have been found to be the most efficacious of three kinds of clinically tested dental tissue-derived stem cells, according to
The Institute of Medicine (IOM) has released its “Advancing Oral Health in America” report, which emphasizes the inextricable link between a person’s oral health and
The Cuyahoga County coroner in Ohio has ruled that a 13-year-old girl’s death in January — two weeks after she had two teeth extracted —
Milestone Scientific reported revenues of $9.75 million for 2010 (end-December 31, 2010), up 14% from $8.55 million in the previous year. Sales in the U.S.
A detailed informed consent process is important before the start of any orthodontic treatment, but a study presented at the recent International Association for Dental
Two U.S. congressmen are urging the Department of Veterans Affairs (VA) to establish a dedicated task force to investigate issues surrounding misconduct at the Dayton
Biodental Remin is entering into a joint venture partnership with Red Seal Natural Health to manufacture and distribute dental and oral hygiene products using Biodental
The U.S. Food and Drug Administration (FDA) has approved vandetanib to treat adult patients with late-stage medullary thyroid cancer who are ineligible for surgery and